- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05471349
Message Testing in Older Adult Smokers
January 5, 2024 updated by: University of Wisconsin, Madison
Message Testing in Older Adult Smokers (MCAS-2)
This study is examining different messages to motivate older smokers to quit smoking.
Participants will be current smokers, between the ages of 50-80 years old, who do not have a history of cognitive impairment or dementia.
Participants can expect to take part in a one-time 30 minute online survey.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
820
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Wisconsin
-
Madison, Wisconsin, United States, 53705
- University of Wisconsin
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Current smoker (smoking at least some days per week)
- Ability to read and write English
- Between the ages of 50 and 80 years old
Exclusion Criteria:
- History of Mild Cognitive Impairment or dementia
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Hope message
Participants will view a hope-based video message and flyer.
|
Participants will view a flyer and video
|
|
Active Comparator: Fear message
Participants will view a fear-based video message and flyer.
|
Participants will view a flyer and video
|
|
Placebo Comparator: Control message
Participants will view a water advertisement video and flyer.
|
Participants will view a flyer and video
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Emotional Response
Time Frame: Through study completion, approximately 30 minutes
|
Measure participants' emotional response to the messages using a 1-9 scaled measurement of 14 different emotions (9 indicating more emotional response).
Emotionality will be presented together summarizing the mean presentation of these emotions by the different groups.
|
Through study completion, approximately 30 minutes
|
|
Motivation to Quit
Time Frame: Through study completion, approximately 30 minutes
|
Measure participants' motivation to quit after viewing the flyer and video, using a 1 item scaled measurement of motivation to quit (1-7 scale, 7 indicating higher motivation).
|
Through study completion, approximately 30 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Adrienne Johnson, PhD, University of Wisconsin, Madison
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 12, 2022
Primary Completion (Actual)
July 18, 2022
Study Completion (Actual)
July 18, 2022
Study Registration Dates
First Submitted
July 20, 2022
First Submitted That Met QC Criteria
July 21, 2022
First Posted (Actual)
July 22, 2022
Study Record Updates
Last Update Posted (Estimated)
January 31, 2024
Last Update Submitted That Met QC Criteria
January 5, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 2022-0624 (Other Identifier: UW Madison)
- A534253 (Other Identifier: UW- Madison)
- SMPH/MEDICINE/GEN INT MD (Other Identifier: UW Madison)
- 1K23AG067929-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
National Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Cigarette Smoking | Tobacco, SmokingUnited States
-
University of VirginiaRecruitingSmoking | Smoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking, Cigarette | Quitting SmokingUnited States
-
University GhentActive, not recruitingSmoking | Smoking Tobacco | Smoking Prevention | Smoking CigaretteBelgium
-
Medical University of South CarolinaCompletedSmoking | Smoking Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Maastricht University Medical CenterThe Investigative Desk; SEO Amsterdam Economics; IVO Research InstituteEnrolling by invitationSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking BehaviorsNetherlands
-
Jennifer Marler, MDCompletedSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking BehaviorsUnited States
-
Johns Hopkins UniversityNational Center for Advancing Translational Sciences (NCATS); Community Partnership...CompletedSmoking Cessation | Smoking Reduction | Smoking, TobaccoUnited States
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)Completed
-
Virginia Polytechnic Institute and State UniversityCompletedCigarette Smoking Behavior | Smoking Behaviors | CigaretteUnited States
Clinical Trials on Flyer and video
-
University of Wisconsin, MadisonCentiment LLCCompletedSmoking | Smoking CessationUnited States
-
University of Colorado, DenverCompletedProstate Cancer ScreeningUnited States
-
University of TennesseeMerck Sharp & Dohme LLC; American Pharmacists AssociationCompletedHerpes ZosterUnited States
-
University of ManitobaCanadian Lung AssociationNot yet recruitingInterstitial Lung Disease (ILD)
-
University of Colorado, DenverNational Cancer Institute (NCI); High Plains Research NetworkCompletedSmoking Cessation | Lung CancerUnited States
-
Auburn UniversityAgency for Healthcare Research and Quality (AHRQ)CompletedImmunizationUnited States
-
Université de SherbrookeUniversity of British Columbia; University of Toronto; Dalhousie UniversityCompleted
-
Observatoire Regional de la Sante Provence-Alpes-Côte...Université de Sherbrooke; Hospital St. Joseph, Marseille, France; CRES PACA Marseille and other collaboratorsCompleted
-
University of JordanCompletedProficiency in Computer Interpretation of the ECGJordan
-
Covered CaliforniaActive, not recruitingOutreach InterventionUnited States